Granulomatosis polyangiitis associated with meningeal involvement: Response to rituximab therapy after failure of cyclophosphamide

Maurizio Benucci, F. Li Gobbi, P. Panconesi, M. Manfredi, P. Sarzi-Puttini, F. Atzeni

Research output: Contribution to journalArticle

Abstract

Wegener's granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a 37 year old female patient presenting with upper respiratory tract involvement, chronic rhinosinusitis with green secretions, and bilateral hypoacusia. Ten months later, she suffered occipital headache and two episodes of lipothymia associated with nausea, photophobia, faintness with visual blurring. Magnetic resonance imaging (MRI) revealed aseptic meningitis. The patient was treated with steroids and cyclophosphamide without any effect on the neurological symptoms which, however, greatly improved after subsequent treatment with rituximab as confirmed by means of cerebral MRI. Rituximab is an optimal means of treating cyclophosphamide-resistant patients with GPA associated with meningeal involvement.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalReumatismo
Volume65
Issue number2
DOIs
Publication statusPublished - 2013

Fingerprint

Granulomatosis with Polyangiitis
Cyclophosphamide
Respiratory System
Magnetic Resonance Imaging
Aseptic Meningitis
Photophobia
Glomerulonephritis
Vasculitis
Nausea
Blood Vessels
Headache
Therapeutics
Steroids
Inflammation
Rituximab

Keywords

  • Granulomatosis polyangiitis associated
  • Rituximab

ASJC Scopus subject areas

  • Rheumatology

Cite this

Granulomatosis polyangiitis associated with meningeal involvement : Response to rituximab therapy after failure of cyclophosphamide. / Benucci, Maurizio; Li Gobbi, F.; Panconesi, P.; Manfredi, M.; Sarzi-Puttini, P.; Atzeni, F.

In: Reumatismo, Vol. 65, No. 2, 2013, p. 82-86.

Research output: Contribution to journalArticle

Benucci, Maurizio ; Li Gobbi, F. ; Panconesi, P. ; Manfredi, M. ; Sarzi-Puttini, P. ; Atzeni, F. / Granulomatosis polyangiitis associated with meningeal involvement : Response to rituximab therapy after failure of cyclophosphamide. In: Reumatismo. 2013 ; Vol. 65, No. 2. pp. 82-86.
@article{6212bb6000444964b4b9479cffc5236d,
title = "Granulomatosis polyangiitis associated with meningeal involvement: Response to rituximab therapy after failure of cyclophosphamide",
abstract = "Wegener's granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a 37 year old female patient presenting with upper respiratory tract involvement, chronic rhinosinusitis with green secretions, and bilateral hypoacusia. Ten months later, she suffered occipital headache and two episodes of lipothymia associated with nausea, photophobia, faintness with visual blurring. Magnetic resonance imaging (MRI) revealed aseptic meningitis. The patient was treated with steroids and cyclophosphamide without any effect on the neurological symptoms which, however, greatly improved after subsequent treatment with rituximab as confirmed by means of cerebral MRI. Rituximab is an optimal means of treating cyclophosphamide-resistant patients with GPA associated with meningeal involvement.",
keywords = "Granulomatosis polyangiitis associated, Rituximab",
author = "Maurizio Benucci and {Li Gobbi}, F. and P. Panconesi and M. Manfredi and P. Sarzi-Puttini and F. Atzeni",
year = "2013",
doi = "10.4081/reumatismo.2013.82",
language = "English",
volume = "65",
pages = "82--86",
journal = "Reumatismo",
issn = "0048-7449",
publisher = "PAGEPRESS PUBL",
number = "2",

}

TY - JOUR

T1 - Granulomatosis polyangiitis associated with meningeal involvement

T2 - Response to rituximab therapy after failure of cyclophosphamide

AU - Benucci, Maurizio

AU - Li Gobbi, F.

AU - Panconesi, P.

AU - Manfredi, M.

AU - Sarzi-Puttini, P.

AU - Atzeni, F.

PY - 2013

Y1 - 2013

N2 - Wegener's granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a 37 year old female patient presenting with upper respiratory tract involvement, chronic rhinosinusitis with green secretions, and bilateral hypoacusia. Ten months later, she suffered occipital headache and two episodes of lipothymia associated with nausea, photophobia, faintness with visual blurring. Magnetic resonance imaging (MRI) revealed aseptic meningitis. The patient was treated with steroids and cyclophosphamide without any effect on the neurological symptoms which, however, greatly improved after subsequent treatment with rituximab as confirmed by means of cerebral MRI. Rituximab is an optimal means of treating cyclophosphamide-resistant patients with GPA associated with meningeal involvement.

AB - Wegener's granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a 37 year old female patient presenting with upper respiratory tract involvement, chronic rhinosinusitis with green secretions, and bilateral hypoacusia. Ten months later, she suffered occipital headache and two episodes of lipothymia associated with nausea, photophobia, faintness with visual blurring. Magnetic resonance imaging (MRI) revealed aseptic meningitis. The patient was treated with steroids and cyclophosphamide without any effect on the neurological symptoms which, however, greatly improved after subsequent treatment with rituximab as confirmed by means of cerebral MRI. Rituximab is an optimal means of treating cyclophosphamide-resistant patients with GPA associated with meningeal involvement.

KW - Granulomatosis polyangiitis associated

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=84878470792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878470792&partnerID=8YFLogxK

U2 - 10.4081/reumatismo.2013.82

DO - 10.4081/reumatismo.2013.82

M3 - Article

AN - SCOPUS:84878470792

VL - 65

SP - 82

EP - 86

JO - Reumatismo

JF - Reumatismo

SN - 0048-7449

IS - 2

ER -